Beam Therapeutics Inc (NASDAQ: BEAM) on Tuesday, soared 3.06% from the previous trading day, before settling in for the closing price of $17.01. Within the past 52 weeks, BEAM’s price has moved between $13.52 and $35.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -20.88% over the last five years. The company achieved an average annual earnings per share of -0.41%. With a float of $89.62 million, this company’s outstanding shares have now reached $100.56 million.
The firm has a total of 483 workers. Let’s measure their productivity. In terms of profitability, gross margin is 74.06%, operating margin of -677.47%, and the pretax margin is -609.18%.
Beam Therapeutics Inc (BEAM) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Beam Therapeutics Inc is 10.88%, while institutional ownership is 88.04%. The most recent insider transaction that took place on Apr 01 ’25, was worth 104,122. In this transaction Chief Legal Officer of this company sold 5,674 shares at a rate of $18.35, taking the stock ownership to the 117,294 shares. Before that another transaction happened on Apr 01 ’25, when Company’s CEO sold 30,663 for $18.35, making the entire transaction worth $562,684. This insider now owns 986,249 shares in total.
Beam Therapeutics Inc (BEAM) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -0.41% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.84% during the next five years compared to -20.88% drop over the previous five years of trading.
Beam Therapeutics Inc (NASDAQ: BEAM) Trading Performance Indicators
Beam Therapeutics Inc (BEAM) is currently performing well based on its current performance indicators. A quick ratio of 8.81 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 27.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.61, a number that is poised to hit -1.11 in the next quarter and is forecasted to reach -4.64 in one year’s time.
Technical Analysis of Beam Therapeutics Inc (BEAM)
Analysing the last 5-days average volume posted by the [Beam Therapeutics Inc, BEAM], we can find that recorded value of 2.08 million was better than the volume posted last year of 1.96 million. As of the previous 9 days, the stock’s Stochastic %D was 46.16%.
During the past 100 days, Beam Therapeutics Inc’s (BEAM) raw stochastic average was set at 18.43%, which indicates a significant decrease from 60.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.71% in the past 14 days, which was lower than the 81.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.70, while its 200-day Moving Average is $23.15. Now, the first resistance to watch is $18.31. This is followed by the second major resistance level at $19.09. The third major resistance level sits at $19.96. If the price goes on to break the first support level at $16.67, it is likely to go to the next support level at $15.81. Should the price break the second support level, the third support level stands at $15.03.
Beam Therapeutics Inc (NASDAQ: BEAM) Key Stats
Market capitalization of the company is 1.76 billion based on 100,557K outstanding shares. Right now, sales total 63,520 K and income totals -376,740 K. The company made 7,470 K in profit during its latest quarter, and -109,270 K in sales during its previous quarter.
